Slovene Drug Company Lek Penetrates American Market
Ljubljana, 4 July - SLOVENIA/USA/LEK
American federal Food and Drug Administration (FDA) last week issued a registration certificate for the drug Cimetidin in form of tablets produced by the Slovene stock company Lek. Lek has become the first Central and East European as well as Slovene company to have been given opportunity to launch and sell an end product drug in the demanding American market, reported Lek Tuesday.
The rest of this news item is available to subscribers.
The news item consists of 446 characters (without spaces) or 86 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.